|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-12-23
|
|
pubmed:abstractText |
In our previous work, patients affected by SSc were treated with intravenous urokinase and showed clinical improvement. In this study we used microscopy to document ultrastructural alterations occurring in sclerodermic skin from SSc patients treated with urokinase.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-9742
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
261-7
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:14690137-Adult,
pubmed-meshheading:14690137-Aged,
pubmed-meshheading:14690137-Capillaries,
pubmed-meshheading:14690137-Collagen,
pubmed-meshheading:14690137-Extracellular Matrix,
pubmed-meshheading:14690137-Female,
pubmed-meshheading:14690137-Humans,
pubmed-meshheading:14690137-Injections, Intravenous,
pubmed-meshheading:14690137-Middle Aged,
pubmed-meshheading:14690137-Plasminogen Activators,
pubmed-meshheading:14690137-Scleroderma, Systemic,
pubmed-meshheading:14690137-Skin,
pubmed-meshheading:14690137-Treatment Outcome,
pubmed-meshheading:14690137-Urokinase-Type Plasminogen Activator
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Clinical improvement in systemic sclerosis resulting from urokinase therapy explained by light and electron microscopy skin examination.
|
|
pubmed:affiliation |
Rheumatic Diseases Unit, Medica Santa Chiara Hospital, Pisa, Italy. l.bazzichi@int.med.unipi.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
